
Cellactose 80 is a spray-dried compound consisting of 75 % α-lactose
monohydrate [Ph.Eur./USP-NF/JP] and 25 % cellulose powder dry matter. Cellactose
80, designed especially for direct tableting, combines filling and binding
properties of the two excipients which have been synergistically combined to an
one-body excipient providing better tableting performance at lower
cost.
Cellactose 80 is
an inovative filler-binder particularly designed and co-processed for direct
compression. Cellactose 80 is a spraydried one-body-compound consisting of 75%
alpha-lactose monohydrate and 25% cellulose powder. The advantage of copressing
is the synergistic effect of both components, i.e. enhanced compressibility of
pure lactose and highly increased flowability of cellulose powder. Spraydrying
leads to almost spherical particles of Cellactose 80. It is the content of
cellulose that is responsible for its excellent binding capacity. Due to the
excellent compressibility of Cellactose 80 tablets with good properties can be
obtained at low compression forces. The most obvious advantages of Cellactose 80
are compressibility, flowability, stability, adherence capacity, and pleasant
taste. Cellactose 80 is mainly used for high-dosage tablet and for herbal
formulations. Cellactose 80 shows superior adherence capacity for small sized
actives and therefore provides a very good content uniformity.
Cellactose 80 1
spraydried body 75% of α-lactose monohydrate and 25% cellulose powder compounds.
The advantage copressing two components, that is pure lactose enhanced the
mobility of the compressibility and high-cellulose powder increased synergies.
Spraydrying lead almost Cellactose 80 spherical particles. It is the cellulose
content is responsible for its good binding capacity. With the performance
Cellactose 80 slices good compression, you can get at low compression force.
Cellactose 80 The most obvious advantage is that the compressibility, mobility,
stability, and the ability to hold and pleasant taste.
Readmore:Cellactose
80 online
Reprint:http://www.chem-pharma.net/blog/view.asp?id=4
没有评论:
发表评论